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A B ST R AC T  
 
Wilms tumor (WT) is the most common childhood tumor of the kidney, which histologically mimics 
various stages of nephrogenesis. Spectrum of chemotherapy induced histopathological changes has 
been described in literature, and is one of the most important predictors of disease outcome and 
survival rates. Extensive chondroid differentiation and absence of necrosis in a post-chemotherapy 
nephrectomy specimen of a radiologically proven Wilms tumor is an unusual finding. Herein, we 
present the case of 6-year-old girl from South Africa who received a 10-week course of chemotherapy 
upon radiological diagnosis of WT, and post-surgery nephrectomy specimen revealed extensive 
mature cartilage island formation on histology raising diagnostic dilemma. Reporting of such cases 
is extremely important to recognize tumor morphological heterogeneity, particularly post- 
chemotherapy, and developing consensus for selecting further treatment and clinical follow-up. 
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Introduction 
Wilms tumor (WT) is the most common 
childhood tumor of the kidney, constituting 6 
to 7% of childhood cancer in developed 
countries, [1] and accounts for approximately 
12% of all childhood cancers in the 
underdeveloped countries [2]. WT mimics 
normal nephrogenesis, and histologically is 
composed of a variable admixture of epithelial, 
blastemal and stromal components [3]. 
Heterologous components i.e. striated and 
smooth muscle, cartilage, bone, adipose tissue, 
etc. are present in only 10% of WT [4]. 
Recently, studies have shown that two-hit 
inactivation of the WT1 gene is more prevalent 
in stromal-predominant WT [4]. Currently, 
pre-chemotherapy/ up-front surgery-based 
system developed by the National Wilms 
Tumor Study Group (NWTSG) and post-
chemotherapy- based system developed by the 
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International Society of Pediatric Oncology 
(SIOP) are the treatment strategies selected 
based on individual patient risk of tumor 
spillage, rupture and recurrence [5]. Patients 
following SIOP protocol usually do not 
undergo a biopsy prior to starting therapy [5]. 
Preoperative chemotherapy is known to affect 
original tumor histology, sometimes 
drastically, resulting in reduced or enhanced 
individual tumor components, and often 
inducing maturation [6,7]. WT has good 
prognosis with survival rate of 90% in 
developed countries following either regime 
[1,2]. Tumor stage and histopathological 
features following neoadjuvant chemotherapy 
as well as after upfront surgery are the most 
important predictors of disease outcome and 
survival rates [5]. Herein, we present a case of 
6-year-old girl from South Africa who 
received 10 weeks course of chemotherapy 
upon radiological diagnosis of WT, and post-
surgery nephrectomy specimen revealed 
extensive mature cartilage island formation on 
histology raising diagnostic dilemma. 
Reporting of such cases is extremely important 
to recognize tumor morphological 
heterogeneity and assess response following 
chemotherapy. Indeed, requires developing 
consensus for selecting further treatment 
course for such cases.  
 
Case report 
A 6-year-old girl from South Africa presented 
to the pediatric surgery out-patient department 
with a complaint of swelling in the right flank. 
The swelling was first noticed by her parents 8 
months ago, when the size was that of a lemon. 
However, they found a rapid increase in the 
size of the swelling. History of fever, pain 
abdomen, hematuria, and hypertension was 
absent. Past medical history was non-
contributory. Contrast enhanced CT revealed a 
large heterogeneously enhancing mass 
measuring 17 X 16 X 11 cm with well-defined 
margins arising from lower pole of the right 
kidney. The mass extended from T11 to S1 
vertebral body, crossing the midline. Right 
renal vein and inferior vena cava (IVC) were 
free of thrombus (Fig. 1; A, B & C). A 
radiological diagnosis of Wilms tumor was 
suggested. Pre-operative fine needle aspiration 
cytology (FNAC) was not done. With this 
diagnosis patient was started on chemotherapy. 
DD4A regimen (vincristine, dactinomycin, 
and doxorubicin) was administered for 10 
weeks. Post-chemotherapy CECT revealed 
reduction in size of the tumor to 15X9 cm with 
change in the internal attenuation and 
enhancement pattern (Fig. 1; D, E & F). Right 
nephrectomy and hilar lymph node dissection 
was undertaken.  
On histopathological examination, the right 
nephrectomy specimen measured 20X13X10 
cm, weighing 1325 grams (Fig. 2). Attached 
ureter measured 10.5 cm in length and 0.6 cm 
diameter. External surface of the kidney was 
bosselated with a thick, adherent capsule. 
Serial slicing showed a large well encapsulated 
mass replacing almost the entire renal 
parenchyma, with a thin rim of normal renal 
tissue at the lower pole. Cut surface of the 
tumor was lobulated, firm, pearly white to 
myxoid, with intervening pin-point yellowish 
areas. Focal fleshy areas were also identified. 
Microscopic examination from different tumor 
areas predominantly showed islands of mature 
cartilage lacking nuclear atypia 
(approximately 80% of tumor area), 
surrounded by nondescript mesenchyme with 
focal myxoid stroma (approximately 15%). At 
places, skeletal muscle differentiation was 
noted (approximately 5%), along with areas of 
hyalinization. Epithelial, blastemal or 
malignant stromal component were not seen.  
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Necrosis was present in less than 1% of the 
total area sampled. MIB-1 labeling index was 
negligible in the chondroid islands (Fig. 3). 
Differential diagnoses considered were 
stromal-predominant WT with heterologous 
elements, ossifying renal tumor of infancy and 
intrarenal teratoma. Immunohistochemistry 
(Fig. 4a, b) for WTI showed cytoplasmic and 
nuclear staining in the skeletal muscle 
component and helped to confirm the 
diagnosis. Non-descript stroma showed 
negative staining for smooth muscle actin, 
desmin, myogenin and S100. Based on the 
post-chemotherapy induced histological 
changes in form of predominance of chondroid 
elements and WT1 staining in the skeletal 
muscle component, a final diagnosis of 
stromal-predominant WT with extensive 
chondroid differentiation was made. 
Thereafter, patient received radiotherapy to the  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
flank 10.8 Gy/6 cycle for six days and adjuvant 
chemotherapy planned upto 24 weeks as per 
DD4A regimen. 
 
Discussion 
Histologically, WT mimics various stages of 
nephrogenesis [4]. Depending upon the 
components present, it can be mesenchymal 
predominant, epithelial or mixed.  WT 
containing heterologous element are 
considered to arise from intralobar 
nephrogenic rests (ILNRs) rich in stroma [4]. 
Fetal rhabdomyomatous WT containing 
abundant skeletal muscle are chemoresistant 
and often shows poor volumetric response has 
been described in literature [7,8]. Presence of 
extensive cartilaginous differentiation along 
with foci of rhabdomyomatous differentiation, 
and the complete absence of necrosis, tubules, 
blastema and epithelial component in the index  
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case is an unusual type of tumor response to 
chemotherapy in a radiologically proven WT.  
In routine practice, the diagnosis of Wilms 
tumor relies on classical morphological 
features supplemented by nuclear staining for 
WT1 on immunohistochemistry [9]. WT1 
shows strong nuclear expression in majority of 
cases, particularly in epithelial and blastemal 
components, while it may be extremely low or 
even absent in stromal components [4]. WT1 
gene mutation is present in approximately 15 
to 20% of WT [9]. However, recently, 
germline mutations have also been described 
in the majority of stromal-predominant WTs, 
leading to ectopic myogenesis [4]. In such a 
setting, the gene product of WT1 is aberrantly 
expressed in the cytoplasm of tumor cells, 
indicating arrest of mesenchymal to epithelial 
lineage transformation, and this can be 
detected by immunohistochemistry using an 
antibody against the N-terminus of WT1 [4]. 
Cytoplasmic WT1 expression in the skeletal 
muscle component in the present case thus 
supported the diagnosis of WT, although only 
focal nuclear staining was seen.   
Studies have shown that chemotherapeutic 
agents used in treatment of WT induce necrosis 
of immature and actively proliferating cells i.e. 
the blastemal component, and cell maturation 
in         other     components     [6,9,10].     The  
 
 
 
 
 
 
 
 
 
 
 
 
differentiated component appears 
histologically benign with negligible 
proliferating index [10]. However, rate at 
which the therapeutic agents induce 
differentiation process i.e. rhabdomyomatous 
and chondromatous is still unknown [7,10]. In 
the present case, extensive cartilaginous 
differentiation presumably represents a 
maturation response following chemotherapy, 
or survival of well differentiated component in 
the original tumor population. The lack of 
evidence of chondroid differentiation on 
preoperative imaging favors the former over 
the latter. Absence of necrosis after 
chemotherapy is also suggestive of a stromal 
predominant WT lacking blastemal or other 
rapidly proliferating components. Reduction in 
tumor volume after chemotherapy is a measure 
of clinical response for determining 
postoperative treatment. Stromal predominant 
WTs are known not to reveal volume reduction 
post-chemotherapy [6,10]. In the index case, 
there was only slight reduction in tumor 
volume, suggesting poor volumetric response 
and need for further therapeutic intervention, 
and further supporting our hypothesis that 
extensive cartilaginous differentiation in the 
present case occurred as a maturation of 
stromal component following chemotherapy. 
However, studies have supported that poor 
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volumetric response may not represent 
treatment failure or aggressive tumor behavior 
[10,11]. 
 
Conclusion 
Extensive presence of heterologous elements 
may confound the histological diagnosis in 
absence of classical triphasic appearance of 
WT. Volumetric response is not the only 
measure of response to chemotherapy; 
maturation and terminal differentiation to 
benign stromal derivatives without volume 
reduction can also be considered a response to 
chemotherapy, limiting its metastatic potential.  
 
Compliance with ethical statements 
Conflicts of Interest:   None.  
Financial disclosure:   None.  
Consent: All photos were taken with parental 
consent. 
 
ORCID ID of the authors 
Kalpana Kumari /0000-0002-8396-6809 
Priyanka Naranje /0000-0002-3147-8643 
Tripti Nakra /0000-0001-9907-7531 
Seema Kaushal /0000-0002-6190-5909 
Diya Roy /0000-0002-0175-7641 
Saket Davera /0000-0002-6211-2134 
Sandeep Agarwal /0000-0002-8345-6678 
Ahitagni Biswas /0000-0002-3453-5340 
Venkateswaran K. Iyer /0000-0003-1933-7562 
Amit Kumar Dinda /0000-0002-5840-1830 
 
References  
[1] Poole J. Wilm’s tumour. CME. 2010; 28(7): 
307, 324-326. 
[2] Stefan DC, Stones DK. The South African 
Paediatric Tumour Registry - 25 years of 
activity. S Afr Med J. 2012;102(7):605-6. 
[3] Beckwith JB, Kiviat NB, Bonadio JF. 
Nephrogenic rests, nephroblastomatosis 
and the pathogenesis of Wilms’ tumor. 
Pediatr Pathol. 1990;10(1-2): 1-36. 
[4] Schumacher V, Schuhen S, Sonner S, et al. 
Two molecular subgroups of Wilms’ 
tumors with or without WT1 mutations. 
Clin Cancer Res. 2003; 9(6): 2005-14. 
[5] Weirich A, Leuschner I, Harms D, et al. 
Clinical impact of histologic subtypes in 
localized non-anaplastic nephroblastoma 
treated according to the trial and study 
SIOP-9/GPOH. Ann Oncol. 2001;12(3): 
311-19. 
[6] Shibata R, Takata A, Hashiguchi A, et al. 
Responsiveness of chemotherapy based on 
the histological type and Wilms’ tumor 
suppressor gene mutation in bilateral 
Wilms’ tumor. Pathol Int. 2003; 53(4): 214-
20. 
[7] Seifert RP, McNab P, Sexton WJ, et al. 
Rhabdomyomatous differentiation in 
Wilms tumor pulmonary metastases: a case 
report and literature review. Ann Clin Lab 
Sci. 2012;42(4):409-16. 
[8] Maes P, Delemarrem J, de Krakerm J, et al. 
Fetal rhabdomyomatous nephroblastoma: a 
tumor of good prognosis but resistant to 
chemotherapy. Eur J Cancer. 1999; 
35(9):1356-60.  
[9] Geller JI. Genetic stratification of Wilms 
tumor: is WT1 gene analysis ready for 
prime time? Cancer. 2008;113(5):893-96. 
[10] Anderson J, Slater O, McHugh K, et al. 
Response without shrinkage in bilateral 
Wilms tumor: significance of 
rhabdomyomatous histology. J Pediatr 
Hematol Oncol. 2002; 24(1): 31-34. 
[11]  Sreeranga YL, Anil Kumar N, Tyagi A, et 
al. Monophasic Wilms’ tumor with multiple 
skeletal metastases in a young female: A 
case report and review of literature. Pediatr 
Urol Case Rep. 2016;3(3):68-75.
 
